Related Experiment Videos
Cytogenetics in pediatric low-grade astrocytomas.
Lesley C Orr1, Julie Fleitz, Loris McGavran
1University of Colorado Health Sciences Center, Denver, Colorado, USA.
Medical and Pediatric Oncology
|February 12, 2002
Summary
Cytogenetic analysis does not appear to predict survival in pediatric low-grade astrocytomas (LGA). Histologic grade is a more significant factor for predicting outcomes in these pediatric brain tumors.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Cytogenetics
Background:
- Cytogenetic analysis is crucial for tumor classification and prognosis.
- Limited research exists on cytogenetic analysis in pediatric brain tumors, particularly low-grade astrocytomas (LGA).
- Adult LGA studies suggest better survival with normal cytogenetics, prompting investigation in children.
Purpose of the Study:
- To investigate the correlation between cytogenetic abnormalities and survival in pediatric low-grade astrocytomas.
- To determine if cytogenetic analysis is a significant prognostic factor in childhood LGA.
- To compare prognostic value of cytogenetics versus histologic grade in pediatric LGA.
Main Methods:
- Retrospective study of pediatric patients with LGA between 1980-1998.
- Analysis of informative cytogenetic data from 29 pediatric LGA tumors.
- Comparison of survival rates based on presence or absence of chromosomal abnormalities.
Main Results:
- Of 149 pediatric LGA cases, 29 had successful cytogenetic analysis.
- Eight tumors showed chromosomal abnormalities; 21 had normal karyotypes.
- No significant difference in 5-year progression-free or overall survival between children with normal versus abnormal cytogenetics.
Conclusions:
- Cytogenetic status does not appear to be a significant predictor of prognosis in pediatric low-grade astrocytomas.
- Histologic grade (WHO Grade I vs. Grade II) is a superior predictor of progression-free and overall survival.
- Further research may be needed to identify reliable prognostic markers for pediatric LGA.